Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Irritable Bowel Syndrome (IBS) Market Size Analysis from 2022 to 2027

1.5.1 Global Irritable Bowel Syndrome (IBS) Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Irritable Bowel Syndrome (IBS) Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Irritable Bowel Syndrome (IBS) Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Irritable Bowel Syndrome (IBS) Industry Impact

Chapter 2 Global Irritable Bowel Syndrome (IBS) Competition by Types, Applications, and Top Regions and Countries

2.1 Global Irritable Bowel Syndrome (IBS) (Volume and Value) by Type

2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption and Market Share by Type (2016-2021)

2.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2016-2021)

2.2 Global Irritable Bowel Syndrome (IBS) (Volume and Value) by Application

2.2.1 Global Irritable Bowel Syndrome (IBS) Consumption and Market Share by Application (2016-2021)

2.2.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Application (2016-2021)

2.3 Global Irritable Bowel Syndrome (IBS) (Volume and Value) by Regions

2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Irritable Bowel Syndrome (IBS) Consumption by Regions (2016-2021)

4.2 North America Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

4.10 South America Irritable Bowel Syndrome (IBS) Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Irritable Bowel Syndrome (IBS) Market Analysis

5.1 North America Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

5.1.1 North America Irritable Bowel Syndrome (IBS) Market Under COVID-19

5.2 North America Irritable Bowel Syndrome (IBS) Consumption Volume by Types

5.3 North America Irritable Bowel Syndrome (IBS) Consumption Structure by Application

5.4 North America Irritable Bowel Syndrome (IBS) Consumption by Top Countries

5.4.1 United States Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

5.4.2 Canada Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

5.4.3 Mexico Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 6 East Asia Irritable Bowel Syndrome (IBS) Market Analysis

6.1 East Asia Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

6.1.1 East Asia Irritable Bowel Syndrome (IBS) Market Under COVID-19

6.2 East Asia Irritable Bowel Syndrome (IBS) Consumption Volume by Types

6.3 East Asia Irritable Bowel Syndrome (IBS) Consumption Structure by Application

6.4 East Asia Irritable Bowel Syndrome (IBS) Consumption by Top Countries

6.4.1 China Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

6.4.2 Japan Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

6.4.3 South Korea Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 7 Europe Irritable Bowel Syndrome (IBS) Market Analysis

7.1 Europe Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

7.1.1 Europe Irritable Bowel Syndrome (IBS) Market Under COVID-19

7.2 Europe Irritable Bowel Syndrome (IBS) Consumption Volume by Types

7.3 Europe Irritable Bowel Syndrome (IBS) Consumption Structure by Application

7.4 Europe Irritable Bowel Syndrome (IBS) Consumption by Top Countries

7.4.1 Germany Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.2 UK Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.3 France Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.4 Italy Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.5 Russia Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.6 Spain Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.7 Netherlands Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.8 Switzerland Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

7.4.9 Poland Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 8 South Asia Irritable Bowel Syndrome (IBS) Market Analysis

8.1 South Asia Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

8.1.1 South Asia Irritable Bowel Syndrome (IBS) Market Under COVID-19

8.2 South Asia Irritable Bowel Syndrome (IBS) Consumption Volume by Types

8.3 South Asia Irritable Bowel Syndrome (IBS) Consumption Structure by Application

8.4 South Asia Irritable Bowel Syndrome (IBS) Consumption by Top Countries

8.4.1 India Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

8.4.2 Pakistan Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Irritable Bowel Syndrome (IBS) Market Analysis

9.1 Southeast Asia Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

9.1.1 Southeast Asia Irritable Bowel Syndrome (IBS) Market Under COVID-19

9.2 Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Volume by Types

9.3 Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Structure by Application

9.4 Southeast Asia Irritable Bowel Syndrome (IBS) Consumption by Top Countries

9.4.1 Indonesia Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

9.4.2 Thailand Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

9.4.3 Singapore Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

9.4.4 Malaysia Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

9.4.5 Philippines Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

9.4.6 Vietnam Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

9.4.7 Myanmar Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 10 Middle East Irritable Bowel Syndrome (IBS) Market Analysis

10.1 Middle East Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

10.1.1 Middle East Irritable Bowel Syndrome (IBS) Market Under COVID-19

10.2 Middle East Irritable Bowel Syndrome (IBS) Consumption Volume by Types

10.3 Middle East Irritable Bowel Syndrome (IBS) Consumption Structure by Application

10.4 Middle East Irritable Bowel Syndrome (IBS) Consumption by Top Countries

10.4.1 Turkey Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.3 Iran Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.5 Israel Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.6 Iraq Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.7 Qatar Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.8 Kuwait Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

10.4.9 Oman Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 11 Africa Irritable Bowel Syndrome (IBS) Market Analysis

11.1 Africa Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

11.1.1 Africa Irritable Bowel Syndrome (IBS) Market Under COVID-19

11.2 Africa Irritable Bowel Syndrome (IBS) Consumption Volume by Types

11.3 Africa Irritable Bowel Syndrome (IBS) Consumption Structure by Application

11.4 Africa Irritable Bowel Syndrome (IBS) Consumption by Top Countries

11.4.1 Nigeria Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

11.4.2 South Africa Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

11.4.3 Egypt Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

11.4.4 Algeria Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

11.4.5 Morocco Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 12 Oceania Irritable Bowel Syndrome (IBS) Market Analysis

12.1 Oceania Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

12.2 Oceania Irritable Bowel Syndrome (IBS) Consumption Volume by Types

12.3 Oceania Irritable Bowel Syndrome (IBS) Consumption Structure by Application

12.4 Oceania Irritable Bowel Syndrome (IBS) Consumption by Top Countries

12.4.1 Australia Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

12.4.2 New Zealand Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 13 South America Irritable Bowel Syndrome (IBS) Market Analysis

13.1 South America Irritable Bowel Syndrome (IBS) Consumption and Value Analysis

13.1.1 South America Irritable Bowel Syndrome (IBS) Market Under COVID-19

13.2 South America Irritable Bowel Syndrome (IBS) Consumption Volume by Types

13.3 South America Irritable Bowel Syndrome (IBS) Consumption Structure by Application

13.4 South America Irritable Bowel Syndrome (IBS) Consumption Volume by Major Countries

13.4.1 Brazil Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

13.4.2 Argentina Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

13.4.3 Columbia Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

13.4.4 Chile Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

13.4.5 Venezuela Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

13.4.6 Peru Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

13.4.8 Ecuador Irritable Bowel Syndrome (IBS) Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Irritable Bowel Syndrome (IBS) Business

14.1 Bausch Health

14.1.1 Bausch Health Company Profile

14.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Specification

14.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Sucampo Pharmaceuticals (Mallinckrodt)

14.2.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Profile

14.2.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Specification

14.2.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Allergan

14.3.1 Allergan Company Profile

14.3.2 Allergan Irritable Bowel Syndrome (IBS) Product Specification

14.3.3 Allergan Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Takeda

14.4.1 Takeda Company Profile

14.4.2 Takeda Irritable Bowel Syndrome (IBS) Product Specification

14.4.3 Takeda Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Astellas Pharmaceuticals

14.5.1 Astellas Pharmaceuticals Company Profile

14.5.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Specification

14.5.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Sebela Pharmaceuticals Inc

14.6.1 Sebela Pharmaceuticals Inc Company Profile

14.6.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Specification

14.6.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Irritable Bowel Syndrome (IBS) Market Forecast (2022-2027)

15.1 Global Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Irritable Bowel Syndrome (IBS) Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Irritable Bowel Syndrome (IBS) Value and Growth Rate Forecast (2022-2027)

15.2 Global Irritable Bowel Syndrome (IBS) Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Irritable Bowel Syndrome (IBS) Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Irritable Bowel Syndrome (IBS) Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Irritable Bowel Syndrome (IBS) Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Type (2022-2027)

15.3.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Type (2022-2027)

15.3.3 Global Irritable Bowel Syndrome (IBS) Price Forecast by Type (2022-2027)

15.4 Global Irritable Bowel Syndrome (IBS) Consumption Volume Forecast by Application (2022-2027)

15.5 Irritable Bowel Syndrome (IBS) Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology